Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients
- 31 August 1991
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 4 (4) , 617-630
- https://doi.org/10.1016/0896-8411(91)90181-b
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Anti-CD4 monoclonal antibody administration in renal transplanted patientsClinical Immunology and Immunopathology, 1990
- Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cellsJournal of Autoimmunity, 1989
- Clinical use of OKT3: The role of cytokine release and xenosensitizationJournal of Autoimmunity, 1988
- MONOCLONAL ANTI-CD4 IN ARTHRITISThe Lancet, 1987
- Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD miceDiabetes, 1987
- Involvement of the CD4 molecule in a post‐activation event on T cell proliferationEuropean Journal of Immunology, 1987
- Human leukocyte IgG Fc receptorsImmunology Today, 1986
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- OKT4 AND OKT4A ANTIBODY TREATMENT AS IMMUNOSUPPRESSION FOR KIDNEY TRANSPLANTATION IN RHESUS MONKEYSTransplantation, 1985